BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17445934)

  • 21. Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee.
    Vajro P; Lenta S; Socha P; Dhawan A; McKiernan P; Baumann U; Durmaz O; Lacaille F; McLin V; Nobili V
    J Pediatr Gastroenterol Nutr; 2012 May; 54(5):700-13. PubMed ID: 22395188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonalcoholic fatty liver disease.
    Angulo P
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():52-6. PubMed ID: 17471859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Underdiagnosis of pediatric obesity and underscreening for fatty liver disease and metabolic syndrome by pediatricians and pediatric subspecialists.
    Riley MR; Bass NM; Rosenthal P; Merriman RB
    J Pediatr; 2005 Dec; 147(6):839-42. PubMed ID: 16356443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonalcoholic fatty liver disease: from clinical recognition to treatment.
    Sevastianos VA; Hadziyannis SJ
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):59-79. PubMed ID: 19072371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of weight loss on nonalcoholic fatty liver disease.
    Rafiq N; Younossi ZM
    Semin Liver Dis; 2008 Nov; 28(4):427-33. PubMed ID: 18956298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Non-alcoholic fatty liver disease in children: a new complication of obesity].
    Bocca G; Stolk RP; Scheenstra R; Sauer PJ
    Ned Tijdschr Geneeskd; 2008 Nov; 152(45):2443-7. PubMed ID: 19051794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation and management of obesity-related nonalcoholic fatty liver disease.
    Nugent C; Younossi ZM
    Nat Clin Pract Gastroenterol Hepatol; 2007 Aug; 4(8):432-41. PubMed ID: 17667992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in nonalcoholic fatty liver disease-related hospitalizations in US children, adolescents, and young adults.
    Koebnick C; Getahun D; Reynolds K; Coleman KJ; Porter AH; Lawrence JM; Punyanitya M; Quinn VP; Jacobsen SJ
    J Pediatr Gastroenterol Nutr; 2009 May; 48(5):597-603. PubMed ID: 19412009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment.
    Carter-Kent C; Zein NN; Feldstein AE
    Am J Gastroenterol; 2008 Apr; 103(4):1036-42. PubMed ID: 18177455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects.
    Musso G; Gambino R; Bo S; Uberti B; Biroli G; Pagano G; Cassader M
    Diabetes Care; 2008 Mar; 31(3):562-8. PubMed ID: 18056890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research.
    Patton HM; Sirlin C; Behling C; Middleton M; Schwimmer JB; Lavine JE
    J Pediatr Gastroenterol Nutr; 2006 Oct; 43(4):413-27. PubMed ID: 17033514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic fatty liver disease.
    Hjelkrem MC; Torres DM; Harrison SA
    Minerva Med; 2008 Dec; 99(6):583-93. PubMed ID: 19034256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.
    Rafiq N; Younossi ZM
    Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):207-15. PubMed ID: 19072356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolving trends in nonalcoholic fatty liver disease.
    Delgado JS
    Eur J Intern Med; 2008 Mar; 19(2):75-82. PubMed ID: 18249301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is nonalcoholic fatty liver disease in children the same disease as in adults?
    Hsu E; Murray K
    Clin Liver Dis; 2012 Aug; 16(3):587-98. PubMed ID: 22824482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonalcoholic fatty liver disease in India--is it different?
    Duseja A
    Trop Gastroenterol; 2006; 27(4):142-6. PubMed ID: 17542290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
    Wieckowska A; Papouchado BG; Li Z; Lopez R; Zein NN; Feldstein AE
    Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treating nonalcoholic fatty liver disease.
    Méndez-Sánchez N; Arrese M; Zamora-Valdés D; Uribe M
    Liver Int; 2007 Nov; 27(9):1157-65. PubMed ID: 17919226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathology of nonalcoholic fatty liver disease.
    Yeh MM; Brunt EM
    Am J Clin Pathol; 2007 Nov; 128(5):837-47. PubMed ID: 17951208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.